Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTirzepatide, the active ingredient in Mounjaro, has a half-life of approximately five days, meaning it takes roughly five weeks for a single dose to clear your system almost entirely. That unusually long residence time is why the injection works on a once-weekly schedule, and it has real practical consequences: effects on appetite, digestion and blood sugar continue well beyond injection day. Because Mounjaro is a prescription-only medicine, any decision about pausing, stopping or timing treatment should be made alongside the clinician managing your care, not independently — your full medical picture matters.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The decision most people are working through when they type this question is a practical one: can I pause treatment for a holiday, a procedure or a course of tablets? The answer depends on understanding what a five-day half-life actually does to a medicine's concentration in your body.
A half-life of five days means that five days after your last injection, roughly half the dose remains active. After ten days, about a quarter. The medicine does not vanish abruptly after seven days just because another dose is due. That is precisely why a missed week does not cancel the previous pen's effect entirely, and why the appetite-suppressing, gastric-slowing action carries right through to the next injection day. You can read more about when the effects become noticeable from the point of the first pen on how long Mounjaro takes to work.
Full clearance (defined loosely as five half-lives) lands at around 25 days after the last dose, though measurable concentrations may persist slightly longer. NHS guidance on tirzepatide notes the medicine's pharmacokinetic profile as part of its clinical considerations, and the BNF entry for tirzepatide lists half-life data as a reference point for prescribers. The practical upshot: if you are planning to stop, the medicine's footprint does not disappear the week after your last pen. Your prescriber needs to know.
Between injections, tirzepatide's blood concentration does not drop to zero, it plateaus at a steady-state trough that still carries meaningful pharmacological activity. Appetite reduction, slowed gastric emptying and the influence on blood-sugar regulation are all still present on day seven, which is why the once-weekly schedule works. For a more detailed look at the full picture of how tirzepatide behaves throughout its time in your body, the guide to how long Mounjaro lasts in your system covers the steady-state concept in detail.
When a dose is delayed by a few days, most people notice relatively little change because the trough concentration is still active. Delay beyond a few days and concentrations drop more substantially, which is when appetite may edge back and some people experience a slight return of symptoms, a reminder that the medicine was doing more than they'd noticed. If a full week or more is missed, the prescriber's guidance in the Patient Information Leaflet applies: do not double-dose to catch up.
The practical timing question we hear from people planning trips or working around a Monday order before a bank holiday is real. Payday timing, school holidays, a scheduled procedure, all of these interact with the injection schedule in ways worth raising with your prescribing clinician rather than working around quietly. A prescriber can advise on the least disruptive approach; guessing rarely improves things.
If you stop Mounjaro entirely, the medicine clears across roughly four to five weeks, with concentrations halving every five days. Side effects like nausea generally ease within days of the last injection (faster than the full pharmacological clearance) because the gut sensitisation that drives early nausea is the first effect to settle. You can explore the clearance timeline in more depth at how long before Mounjaro is out of your system.
Weight tends to return after stopping for a significant proportion of people, as the medicine's suppression of appetite and its metabolic effects both fade. Clinical trials reported this pattern clearly: the biological mechanisms that drive weight gain (appetite hormones, energy regulation) gradually reassert once the medicine is gone. That is not a failure of the treatment; it reflects that obesity is a chronic condition, not a short-term one. The full Mounjaro overview covers the evidence and clinical context if you want to read more about how the medicine is positioned for long-term management.
For anyone considering stopping because of side effects rather than choice, the right step is a conversation with the prescribing clinician rather than stopping unilaterally. The clearance guide for stopping Mounjaro also covers what to expect in the weeks after the last dose.
Surgery and anaesthesia: NHS guidance recommends telling every member of your surgical team, including the anaesthetist, that you are taking a GLP-1 medicine like tirzepatide. Slower gastric emptying affects the risk of aspiration under general anaesthesia. Some teams ask patients to stop the injection a week or two before a planned procedure; others apply different protocols. This is a clinical call, not a decision to make from a search result.
Contraception: the NHS flags that tirzepatide may reduce absorption of oral contraceptive pills for the first four weeks of treatment and for four weeks after each dose increase, because gastric emptying affects how consistently the pill is absorbed. Women taking oral contraceptives are advised to add a barrier method during those windows. If this applies to you, our clinical FAQs point you toward the right conversation to have with your prescriber, and NHS England's guidance on weight-management injections covers the contraception point in detail.
Pregnancy planning: tirzepatide is not recommended during pregnancy, breastfeeding or when actively trying to conceive. MHRA guidance advises using contraception throughout treatment and for a wash-out period before conception is planned. The exact period should be confirmed with your prescriber rather than estimated from a general clearance calculation. More on the cost and clinical context of private treatment (including how pricing has shifted since the 2025 list-price increase) is covered on the page on the Eli Lilly UK price change, if that is part of your planning too. If you have questions about whether Mounjaro is suitable for your specific circumstances, starting a free consultation with our prescribers is the direct route to a clinical answer.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.